Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Airways

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 14.3%Low 2 · 28.6%Moderate 3 · 42.9%High 1 · 14.3%

FEV1 · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 120 participants
Very low

Pulmonary function % predicted PEF (60 minutes) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 636 participants
Moderate

Clinical severity scores (60 minutes) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1130 participants
Low

Admission to hospital at initial presentation · adults and children with acute exacerbation of asthma

MgSO4 + SABA + ipratropium showed no clear difference in admission at first presentation compared with SABA + ipratropium (moderate certainty).

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
RR 0.95 [0.91, 1]
4 studies · 1308 participants
Moderate

Patient readmissions · adults and children with acute exacerbation of asthma

MgSO4 + SABA + ipratropium showed no clear difference in readmission (7 to 30 days) compared with SABA + ipratropium (low certainty).

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
RR 1.8 [0.84, 3.87]
2 studies · 750 participants
Low

Serious adverse events (during admission) · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 557 participants
Moderate

Adverse effects Defined as any adverse event occurring post‐admission · adults and children with acute exacerbation of asthma

1 finding from 1 review

Inhaled magnesium sulfate in the treatment of acute asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1197 participants
High